Table 6.
Treatments2 | ||||||
---|---|---|---|---|---|---|
Variables3 | CON | AB | OEO-150 | OEO-300 | SEM | P-value |
GPX1 | 1.03b | 1.18b | 1.78a | 1.48ab | 0.090 | 0.031 |
SOD1 | 1.01ab | 0.56b | 1.35a | 0.63b | 0.108 | 0.048 |
HMOX1 | 1.03ab | 0.77b | 1.58a | 1.25ab | 0.105 | 0.029 |
NRF2 | 1.08b | 1.17b | 1.97a | 1.58ab | 0.133 | 0.004 |
ZO-1 | 1.04 | 1.33 | 1.05 | 0.89 | 0.123 | 0.122 |
OCLN | 1.01 | 1.15 | 1.05 | 1.00 | 0.084 | 0.575 |
CLDN1 | 1.03b | 1.88a | 1.66a | 2.18a | 0.093 | 0.007 |
MUC2 | 1.05b | 1.89a | 1.95a | 1.85a | 0.122 | <0.001 |
AvBD1 | 1.07b | 0.43c | 1.88a | 1.21ab | 0.201 | 0.002 |
MYD88 | 1.05ab | 1.21a | 0.96ab | 0.72b | 0.127 | 0.085 |
TLR4 | 1.08 | 0.98 | 0.92 | 0.86 | 0.130 | 0.344 |
1Data are means with the SEM derived from ANOVA error mean square for n = 6.
2CON, control diet; AB, control diet containing 20 mg/kg virginiamycin; OEO-150, control diet containing 150 mg/kg organic essential oil; OEO-300, control diet containing 300 mg/kd organic essential oil.
3GPX1, glutathione peroxidase 1; SOD1, superoxidate dismutase 1; HMOX1, hemoxygenase 1; NRF2, nuclear factor erthyroid 2-related factor 2; ZO-1 zona occludin 1; OCLN, occludin; CLDN1, claudin 1; MUC2, mucin 2; AvBD1, avian beta defensin 1; MYD88, myeloid differentiation factor 88; TLR4 toll-like receptor 4.
a,b,cMeans within the same row with different superscripts differ significantly (P < 0.05).